000			02011 a2200601 4500
005			20250516082624.0
264		0	_c20120801
008			201208s 0 0 eng d
022			_a1873-2623
024	7		_a10.1016/j.transproceed.2012.01.046 _2doi
040			_aNLM _beng _cNLM
100	1		_aZhongwei, Z
245	0	0	_aNewly defined clinical features and treatment experience of seventh day syndrome following living donor liver transplantation. _h[electronic resource]
260			_bTransplantation proceedings _cMar 2012
300			_a494-9 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aBiomarkers _xblood
650	0	4	_aBlood Coagulation
650	0	4	_aBlood Coagulation Tests
650	0	4	_aChina
650	0	4	_aClinical Enzyme Tests
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xadministration & dosage
650	0	4	_aIrritable Mood
650	0	4	_aLiver Circulation
650	0	4	_aLiver Transplantation _xadverse effects
650	0	4	_aLiving Donors
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMuromonab-CD3 _xadministration & dosage
650	0	4	_aNecrosis
650	0	4	_aPortal Vein _xphysiopathology
650	0	4	_aPostoperative Complications _xdiagnosis
650	0	4	_aPredictive Value of Tests
650	0	4	_aPrimary Graft Dysfunction _xetiology
650	0	4	_aPulse Therapy, Drug
650	0	4	_aRenal Insufficiency _xetiology
650	0	4	_aReoperation
650	0	4	_aRetrospective Studies
650	0	4	_aSteroids _xadministration & dosage
650	0	4	_aSyndrome
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aUltrasonography, Doppler, Color
650	0	4	_afas Receptor _xanalysis
700	1		_aLili, C
700	1		_aBo, W
700	1		_aXiaodong, W
700	1		_aGoupeng, L
773	0		_tTransplantation proceedings _gvol. 44 _gno. 2 _gp. 494-9
856	4	0	_uhttps://doi.org/10.1016/j.transproceed.2012.01.046 _zAvailable from publisher's website
999			_c21615214 _d21615214